Designing Flexible Portfolio Management Processes
Christine Cioffe, V.M.D., Vice President, Enterprise-wide Planning and Portfolio Management, Merck & Co., Inc.
How Can We Translate Lessons Learned from Other Industries into Helpful Tools for Pharma?
Robin G. Foldesy, Ph.D., Vice President, Portfolio Management, Wyeth Research
The Impact of Organizational Culture on Resource and Portfolio Management “Best Practices”
Richard Heaslip, Ph.D., Vice President, Project Management, Wyeth Research
Leveraging the Effectiveness of a Portfolio Management Group
Mellor Hennessy, Ph.D., Global Portfolio Strategist, Business Performance & Continuous Improvement, Global Development, AstraZeneca
Balancing R&D Investments with External Collaborations
A. Maria Dahl, Ph.D., MBA, Vice President, Portfolio Management Oncology, IPSEN
Tracking Project Flow in an R&D Portfolio: A Case Study
Jay Andersen, Ph.D., Senior Research Fellow, Decision Sciences, Eli Lilly and Company
Use of Multi-Objective Analysis in Portfolio Management of Early Stage Projects
Homie Razavi, Ph.D., MBA, Senior Partner, Kromite
Jack Kloeber, Ph.D., Senior Partner, Kromite
Building a Better Portfolio: Investing in the "Best" Mix of Projects in an Optimization Framework
Robert Kaupp, Ph.D., Director, Portfolio & Decision Analysis Group, Johnson & Johnson